Version 5.4
Homo sapiens Protein: UGT3A2
Summary
InnateDB Protein IDBP-474408.3
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol UGT3A2
Protein Name UDP glycosyltransferase 3 family, polypeptide A2
Synonyms
Species Homo sapiens
Ensembl Protein ENSP00000427404
InnateDB Gene IDBG-16333 (UGT3A2)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
Gene Ontology

Molecular Function
Accession GO Term
GO:0008194 UDP-glycosyltransferase activity
GO:0015020 glucuronosyltransferase activity
GO:0016758 transferase activity, transferring hexosyl groups
GO:0030246 carbohydrate binding
Biological Process
GO:0005975 carbohydrate metabolic process
GO:0008152 metabolic process
GO:0030259 lipid glycosylation
GO:0071412 cellular response to genistein
Cellular Component
GO:0016021 integral component of membrane
Protein Structure and Domains
PDB ID
InterPro IPR002213 UDP-glucuronosyl/UDP-glucosyltransferase
IPR007235 Glycosyl transferase, family 28, C-terminal
PFAM PF00201
PF04101
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q3SY77
PhosphoSite PhosphoSite-Q3SY77
TrEMBL F5H377
UniProt Splice Variant
Entrez Gene 167127
UniGene Hs.348941
RefSeq NP_001161788
HUGO HGNC:27266
OMIM
CCDS CCDS54842
HPRD 14111
IMGT
EMBL AC016612 AK075383 AK300751 AY358416 BC103924 BC103925
GenPept AAI03925 AAI03926 AAQ88782 BAC11583 BAG62419

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca